Mirae Asset Global Investments Co., Ltd. Travere Therapeutics, Inc. Transaction History
Mirae Asset Global Investments Co., Ltd.
- $20 Billion
- Q2 2024
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Travere Therapeutics, Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 2,273 shares of TVTX stock, worth $32,617. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,273
Previous 50,178
95.47%
Holding current value
$32,617
Previous $386,000
95.34%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding TVTX
# of Institutions
184Shares Held
89.8MCall Options Held
137KPut Options Held
181K-
Black Rock Inc. New York, NY7.64MShares$110 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY7.5MShares$108 Million0.8% of portfolio
-
Deep Track Capital, LP Greenwich, CT7.37MShares$106 Million1.99% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.62MShares$95 Million0.0% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD4.48MShares$64.3 Million1.14% of portfolio
About Travere Therapeutics, Inc.
- Ticker TVTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 64,173,600
- Market Cap $921M
- Description
- Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...